Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients-Reference-Cited by-同舟云学术

Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients

Published:2021-10-08 Issue:23 Volume:81 Page:6004-6017
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Woitek Ramona,McLean Mary A.^ORCID,Ursprung Stephan,Rueda Oscar M.^ORCID,Manzano Garcia Raquel,Locke Matthew J.,Beer Lucian^ORCID,Baxter Gabrielle,Rundo Leonardo^ORCID,Provenzano Elena,Kaggie Joshua,Patterson Andrew,Frary Amy^ORCID,Field-Rayner Johanna,Papalouka Vasiliki,Kane Justine,Benjamin Arnold J.V.^ORCID,Gill Andrew B.^ORCID,Priest Andrew N.^ORCID,Lewis David Y.^ORCID,Russell Roslin,Grimmer Ashley^ORCID,White Brian,Latimer-Bowman Beth,Patterson Ilse,Schiller Amy,Carmo Bruno,Slough Rhys,Lanz Titus,Wason James^ORCID,Schulte Rolf F.,Chin Suet-Feung,Graves Martin J.,Gilbert Fiona J.^ORCID,Abraham Jean E.,Caldas Carlos,Brindle Kevin M.^ORCID,Sala Evis,Gallagher Ferdia A.^ORCID

Funder

Mark Foundation for Cancer Research

Cancer Research UK Cambridge

Cancer Research UK

Austrian Science Fund

CRUK Cambridge

CRUK

Engineering and Physical Sciences Research Council Cancer Imaging

in Cambridge and Manchester

Addenbrooke's Charitable Trust

NIHR Cambridge Biomedical Research

National Institute for Health Research